Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
pmid:26283448
pmid:25919143
pmid:25297803
pmid:24801915
pmid:24703653
pmid:23789610
pmid:
Meyskens FL and Salmon SE Inhibition of human melanoma colony formation by retinoids. 1979 Cancer Res. pmid:476643
Rajka G and Thune PO On erythema annulare centrifugum-type of psoriasis. 1979 Acta Derm Venereol Suppl (Stockh) pmid:294089
Lassus A Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro 10-9359). 1980 Br. J. Dermatol. pmid:6992833
van der Rhee HJ et al. Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double-blind trial. 1980 Br. J. Dermatol. pmid:6992834
MacKie RM and Dick DC Synthetic retinoids for acne. 1980 Lancet pmid:6108473
Kariniemi AL et al. Treatment of disseminated superficial actinic porokeratosis with a new aromatic retinoid (Ro 10-9359). 1980 Br. J. Dermatol. pmid:7387874
Lutzner MA and Blanchet-Bardon C Oral retinoid treatment of human papillomavirus type 5-induced epidermodysplasia verruciformis. 1980 N. Engl. J. Med. pmid:6245361
Zonnenberg BA et al. [The basal cell nevus syndrome (follow-up of a special case report)]. 1980 Ned Tijdschr Geneeskd pmid:6157998
Viglioglia PA Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatoses. 1980 Br. J. Dermatol. pmid:7437314
Frankel JW et al. Inhibitory effects of an aromatic retinoid (Ro 10-9359) on viral tumorigenesis. 1980 Intervirology pmid:6265402
Watson AB Clinical evaluation of a new oral retinoid RO10 9359 in the treatment of Darier's disease. 1980 Australas. J. Dermatol. pmid:7447813
Orfanos CE Oral retinoids--present status. 1980 Br. J. Dermatol. pmid:6449212
Tsambaos D and Orfanos CE Ultrastructural evidence suggesting an immunomodulatory activity of oral retinoid. Its effect on dermal components in psoriasis. 1981 Br. J. Dermatol. pmid:7459267
Koh CJ et al. Influence of vitamin E on the effect of vitamin A derivatives on digestive glands of rats. 1981 J. Dermatol. pmid:7037896
Zeng Y et al. Inhibitory effect of retinoids on Epstein-Barr virus induction in Raji cells. 1981 Intervirology pmid:6276324
Salamon T [Contribution to the question of keratodermia palmo-plantaris insularis et striata. The phenomenon of the focal character of phenotypic expression of the pathological gene (author's transl)]. 1981 Z. Hautkr. pmid:6454309
Marks R et al. Severe disorders of keratinization: effects of treatment with Tigason (etretinate). 1981 Br. J. Dermatol. pmid:7248177
Burge SM et al. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease. 1981 Br. J. Dermatol. pmid:7248178
Moulopoulou-Karakitsou K et al. An unusual adverse reaction to Ro 10-9359. 1981 Br. J. Dermatol. pmid:7248181
Lauharanta J et al. Reduction of increased polyamine levels in psoriatic lesions by retinoid and PUVA treatments. 1981 Br. J. Dermatol. pmid:7272207
Chang Sing Pang AF et al. Successful treatment of keratoderma hereditaria mutilans with an aromatic retinoid. 1981 Arch Dermatol pmid:6452098
Lauharanta J et al. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis. 1981 Br. J. Dermatol. pmid:7011359
Michaëlsson G et al. The influence of 'Tigason' (Ro 10-9359) on the serum lipoproteins in man. 1981 Br. J. Dermatol. pmid:7284249
Aoyagi T et al. Retinoid stimulates epidermal outgrowth of pig skin explants. 1981 J. Dermatol. pmid:6456286
Retinoids in dermatology. 1981 Lancet pmid:6111638
Fleissner J and Happle R Etretinate in the treatment of juvenile pityriasis rubra pilaris. 1981 Arch Dermatol pmid:7316540
De Mari F et al. Etretinate in bowenoid papulosis. 1981 Lancet pmid:6117716
Blanchet-Bardon C et al. Etretinate in bowenoid papulosis. 1981 Lancet pmid:6118745
Fritsch P Oral retinoids in dermatology. 1981 Int. J. Dermatol. pmid:6453850
Gomez EC Differential effect of 13-cis-retinoic acid and an aromatic retinoid (Ro 10-9359) on the sebaceous glands of the hamster flank organ. 1981 J. Invest. Dermatol. pmid:6936480
Voorhees JJ and Orfanos CE Oral retinoids. Broad-spectrum dermatologic therapy for the 1980s. 1981 Arch Dermatol pmid:6455092
Paravicini U et al. On metabolism and pharmacokinetics of an aromatic retinoid. 1981 Ann. N. Y. Acad. Sci. pmid:6942699
Williams ML and Elias PM Nature of skin fragility in patients receiving retinoids for systemic effect. 1981 Arch Dermatol pmid:6945067
Henderson JM Present and future use of retinoids in Australia. 1981 Australas. J. Dermatol. pmid:7034711
Ruzicka T et al. Syndrome of ichthyosis congenita, neurosensory deafness, oligophrenia, dental aplasia, brachydactyly, clinodactyly, accessory cervical ribs and carcinoma of the thyroid. 1981 Dermatologica pmid:7250456
Goujon C et al. [Does linear psoriasis exist? (author's transl)]. 1981 Ann Dermatol Venereol pmid:7316393
Ansidei V et al. Phospholipid involvement in psoriatic epidermis. 1981 Jan-Feb Ital. J. Biochem. pmid:7251339
Grasa MP et al. [Hypertrophic Darier's disease of unusual intensity. Enzymatic and ultrastructural study and therapeutic response]. 1981 Nov-Dec Actas Dermosifiliogr pmid:7344430
Soppi AM et al. Cell-mediated immunity in Darier's disease: effect of systemic retinoid therapy. 1982 Br. J. Dermatol. pmid:6460522
Mahrle G et al. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients. 1982 Arch Dermatol pmid:7059226
Laharanta J Oedema, a rare adverse reaction to etretinate (Trigason) 1982 Br. J. Dermatol. pmid:7059517
Glazer SD et al. A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis. 1982 J. Am. Acad. Dermatol. pmid:7068976
Lowe NJ et al. Etretinate treatment for psoriasis inhibits epidermal ornithine decarboxylase. 1982 J. Am. Acad. Dermatol. pmid:7068977